Clinical Trials Browser

Recruiting × OTHER × Oligoprogressive × Clear all

NCT04838899 2024-04-12

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Phase NA Recruiting

Oligoprogressive